The national DBS brain tissue network pilot study: Need for more tissue and more standardization

V. Vedam-Mai, N. Krock, M. Ullman, K. D. Foote, W. Shain, K. Smith, A. T. Yachnis, D. Steindler, B. Reynolds, S. Merritt, F. Pagan, J. Marjama-Lyons, Penelope (Penny) Hogarth, A. S. Resnick, P. Zeilman, M. S. Okun

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Over 70,000 DBS devices have been implanted worldwide; however, there remains a paucity of well-characterized post-mortem DBS brains available to researchers. We propose that the overall understanding of DBS can be improved through the establishment of a Deep Brain Stimulation-Brain Tissue Network (DBS-BTN), which will further our understanding of DBS and brain function. The objectives of the tissue bank are twofold: (a) to provide a complete (clinical, imaging and pathological) database for DBS brain tissue samples, and (b) to make available DBS tissue samples to researchers, which will help our understanding of disease and underlying brain circuitry. Standard operating procedures for processing DBS brains were developed as part of the pilot project. Complete datafiles were created for individual patients and included demographic information, clinical information, imaging data, pathology, and DBS lead locations/settings. 19 DBS brains were collected from 11 geographically dispersed centers from across the U.S. The average age at the time of death was 69.3 years (51-92, with a standard deviation or SD of 10.13). The male:female ratio was almost 3:1. Average post-mortem interval from death to brain collection was 10.6 h (SD of 7.17). The DBS targets included: subthalamic nucleus, globus pallidus interna, and ventralis intermedius nucleus of the thalamus. In 16.7% of cases the clinical diagnosis failed to match the pathological diagnosis. We provide neuropatho-logicalfindings from the cohort, and perilead responses to DBS. One of the most important observations made in this pilot study was the missing data, which was approximately 25% of all available data fields. Preliminary results demonstrated the feasibility and utility of creating a National DBS-BTN resource for the scientific community. We plan to improve our techniques to remedy omitted clinical/research data, and expand the Network to include a larger donor pool. We will enhance sample preparation to facilitate advanced molecular studies and progenitor cell retrieval.

Original languageEnglish (US)
Pages (from-to)219-231
Number of pages13
JournalCell and Tissue Banking
Volume12
Issue number3
DOIs
StatePublished - Aug 2011

Fingerprint

Standardization
Brain
Tissue
Deep Brain Stimulation
Research Personnel
Tissue Banks
Ventral Thalamic Nuclei
Subthalamic Nucleus
Globus Pallidus
Brain Death
Brain Diseases
Thalamus
Stem Cells
Demography
Tissue Donors
Databases
Medical imaging
Pathology
Equipment and Supplies
Research

Keywords

  • Adverse events
  • Deep brain stimulation
  • Devices
  • Dystonia
  • Essential tremor
  • Neuromodulation
  • Parkinson's disease
  • Pathology
  • Safety

ASJC Scopus subject areas

  • Transplantation
  • Biomaterials
  • Biomedical Engineering
  • Cell Biology

Cite this

Vedam-Mai, V., Krock, N., Ullman, M., Foote, K. D., Shain, W., Smith, K., ... Okun, M. S. (2011). The national DBS brain tissue network pilot study: Need for more tissue and more standardization. Cell and Tissue Banking, 12(3), 219-231. https://doi.org/10.1007/s10561-010-9189-1

The national DBS brain tissue network pilot study : Need for more tissue and more standardization. / Vedam-Mai, V.; Krock, N.; Ullman, M.; Foote, K. D.; Shain, W.; Smith, K.; Yachnis, A. T.; Steindler, D.; Reynolds, B.; Merritt, S.; Pagan, F.; Marjama-Lyons, J.; Hogarth, Penelope (Penny); Resnick, A. S.; Zeilman, P.; Okun, M. S.

In: Cell and Tissue Banking, Vol. 12, No. 3, 08.2011, p. 219-231.

Research output: Contribution to journalArticle

Vedam-Mai, V, Krock, N, Ullman, M, Foote, KD, Shain, W, Smith, K, Yachnis, AT, Steindler, D, Reynolds, B, Merritt, S, Pagan, F, Marjama-Lyons, J, Hogarth, PP, Resnick, AS, Zeilman, P & Okun, MS 2011, 'The national DBS brain tissue network pilot study: Need for more tissue and more standardization', Cell and Tissue Banking, vol. 12, no. 3, pp. 219-231. https://doi.org/10.1007/s10561-010-9189-1
Vedam-Mai, V. ; Krock, N. ; Ullman, M. ; Foote, K. D. ; Shain, W. ; Smith, K. ; Yachnis, A. T. ; Steindler, D. ; Reynolds, B. ; Merritt, S. ; Pagan, F. ; Marjama-Lyons, J. ; Hogarth, Penelope (Penny) ; Resnick, A. S. ; Zeilman, P. ; Okun, M. S. / The national DBS brain tissue network pilot study : Need for more tissue and more standardization. In: Cell and Tissue Banking. 2011 ; Vol. 12, No. 3. pp. 219-231.
@article{c47db633984444cc863eb5edfc739f18,
title = "The national DBS brain tissue network pilot study: Need for more tissue and more standardization",
abstract = "Over 70,000 DBS devices have been implanted worldwide; however, there remains a paucity of well-characterized post-mortem DBS brains available to researchers. We propose that the overall understanding of DBS can be improved through the establishment of a Deep Brain Stimulation-Brain Tissue Network (DBS-BTN), which will further our understanding of DBS and brain function. The objectives of the tissue bank are twofold: (a) to provide a complete (clinical, imaging and pathological) database for DBS brain tissue samples, and (b) to make available DBS tissue samples to researchers, which will help our understanding of disease and underlying brain circuitry. Standard operating procedures for processing DBS brains were developed as part of the pilot project. Complete datafiles were created for individual patients and included demographic information, clinical information, imaging data, pathology, and DBS lead locations/settings. 19 DBS brains were collected from 11 geographically dispersed centers from across the U.S. The average age at the time of death was 69.3 years (51-92, with a standard deviation or SD of 10.13). The male:female ratio was almost 3:1. Average post-mortem interval from death to brain collection was 10.6 h (SD of 7.17). The DBS targets included: subthalamic nucleus, globus pallidus interna, and ventralis intermedius nucleus of the thalamus. In 16.7{\%} of cases the clinical diagnosis failed to match the pathological diagnosis. We provide neuropatho-logicalfindings from the cohort, and perilead responses to DBS. One of the most important observations made in this pilot study was the missing data, which was approximately 25{\%} of all available data fields. Preliminary results demonstrated the feasibility and utility of creating a National DBS-BTN resource for the scientific community. We plan to improve our techniques to remedy omitted clinical/research data, and expand the Network to include a larger donor pool. We will enhance sample preparation to facilitate advanced molecular studies and progenitor cell retrieval.",
keywords = "Adverse events, Deep brain stimulation, Devices, Dystonia, Essential tremor, Neuromodulation, Parkinson's disease, Pathology, Safety",
author = "V. Vedam-Mai and N. Krock and M. Ullman and Foote, {K. D.} and W. Shain and K. Smith and Yachnis, {A. T.} and D. Steindler and B. Reynolds and S. Merritt and F. Pagan and J. Marjama-Lyons and Hogarth, {Penelope (Penny)} and Resnick, {A. S.} and P. Zeilman and Okun, {M. S.}",
year = "2011",
month = "8",
doi = "10.1007/s10561-010-9189-1",
language = "English (US)",
volume = "12",
pages = "219--231",
journal = "Cell and Tissue Banking",
issn = "1389-9333",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - The national DBS brain tissue network pilot study

T2 - Need for more tissue and more standardization

AU - Vedam-Mai, V.

AU - Krock, N.

AU - Ullman, M.

AU - Foote, K. D.

AU - Shain, W.

AU - Smith, K.

AU - Yachnis, A. T.

AU - Steindler, D.

AU - Reynolds, B.

AU - Merritt, S.

AU - Pagan, F.

AU - Marjama-Lyons, J.

AU - Hogarth, Penelope (Penny)

AU - Resnick, A. S.

AU - Zeilman, P.

AU - Okun, M. S.

PY - 2011/8

Y1 - 2011/8

N2 - Over 70,000 DBS devices have been implanted worldwide; however, there remains a paucity of well-characterized post-mortem DBS brains available to researchers. We propose that the overall understanding of DBS can be improved through the establishment of a Deep Brain Stimulation-Brain Tissue Network (DBS-BTN), which will further our understanding of DBS and brain function. The objectives of the tissue bank are twofold: (a) to provide a complete (clinical, imaging and pathological) database for DBS brain tissue samples, and (b) to make available DBS tissue samples to researchers, which will help our understanding of disease and underlying brain circuitry. Standard operating procedures for processing DBS brains were developed as part of the pilot project. Complete datafiles were created for individual patients and included demographic information, clinical information, imaging data, pathology, and DBS lead locations/settings. 19 DBS brains were collected from 11 geographically dispersed centers from across the U.S. The average age at the time of death was 69.3 years (51-92, with a standard deviation or SD of 10.13). The male:female ratio was almost 3:1. Average post-mortem interval from death to brain collection was 10.6 h (SD of 7.17). The DBS targets included: subthalamic nucleus, globus pallidus interna, and ventralis intermedius nucleus of the thalamus. In 16.7% of cases the clinical diagnosis failed to match the pathological diagnosis. We provide neuropatho-logicalfindings from the cohort, and perilead responses to DBS. One of the most important observations made in this pilot study was the missing data, which was approximately 25% of all available data fields. Preliminary results demonstrated the feasibility and utility of creating a National DBS-BTN resource for the scientific community. We plan to improve our techniques to remedy omitted clinical/research data, and expand the Network to include a larger donor pool. We will enhance sample preparation to facilitate advanced molecular studies and progenitor cell retrieval.

AB - Over 70,000 DBS devices have been implanted worldwide; however, there remains a paucity of well-characterized post-mortem DBS brains available to researchers. We propose that the overall understanding of DBS can be improved through the establishment of a Deep Brain Stimulation-Brain Tissue Network (DBS-BTN), which will further our understanding of DBS and brain function. The objectives of the tissue bank are twofold: (a) to provide a complete (clinical, imaging and pathological) database for DBS brain tissue samples, and (b) to make available DBS tissue samples to researchers, which will help our understanding of disease and underlying brain circuitry. Standard operating procedures for processing DBS brains were developed as part of the pilot project. Complete datafiles were created for individual patients and included demographic information, clinical information, imaging data, pathology, and DBS lead locations/settings. 19 DBS brains were collected from 11 geographically dispersed centers from across the U.S. The average age at the time of death was 69.3 years (51-92, with a standard deviation or SD of 10.13). The male:female ratio was almost 3:1. Average post-mortem interval from death to brain collection was 10.6 h (SD of 7.17). The DBS targets included: subthalamic nucleus, globus pallidus interna, and ventralis intermedius nucleus of the thalamus. In 16.7% of cases the clinical diagnosis failed to match the pathological diagnosis. We provide neuropatho-logicalfindings from the cohort, and perilead responses to DBS. One of the most important observations made in this pilot study was the missing data, which was approximately 25% of all available data fields. Preliminary results demonstrated the feasibility and utility of creating a National DBS-BTN resource for the scientific community. We plan to improve our techniques to remedy omitted clinical/research data, and expand the Network to include a larger donor pool. We will enhance sample preparation to facilitate advanced molecular studies and progenitor cell retrieval.

KW - Adverse events

KW - Deep brain stimulation

KW - Devices

KW - Dystonia

KW - Essential tremor

KW - Neuromodulation

KW - Parkinson's disease

KW - Pathology

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=80053930447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053930447&partnerID=8YFLogxK

U2 - 10.1007/s10561-010-9189-1

DO - 10.1007/s10561-010-9189-1

M3 - Article

C2 - 20589432

AN - SCOPUS:80053930447

VL - 12

SP - 219

EP - 231

JO - Cell and Tissue Banking

JF - Cell and Tissue Banking

SN - 1389-9333

IS - 3

ER -